Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2025)
Historic Interest & Investment Income for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $4.9 million.
- Nurix Therapeutics' Interest & Investment Income fell 2030.74% to $4.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $22.0 million, marking a year-over-year increase of 1135.95%. This contributed to the annual value of $22.0 million for FY2025, which is 1135.95% up from last year.
- As of Q4 2025, Nurix Therapeutics' Interest & Investment Income stood at $4.9 million, which was down 2030.74% from $5.0 million recorded in Q3 2025.
- Nurix Therapeutics' 5-year Interest & Investment Income high stood at $6.5 million for Q1 2025, and its period low was $39000.0 during Q3 2021.
- For the 5-year period, Nurix Therapeutics' Interest & Investment Income averaged around $2.9 million, with its median value being $2.8 million (2023).
- In the last 5 years, Nurix Therapeutics' Interest & Investment Income tumbled by 9422.22% in 2021 and then skyrocketed by 248717.95% in 2022.
- Nurix Therapeutics' Interest & Investment Income (Quarter) stood at $295000.0 in 2021, then surged by 568.81% to $2.0 million in 2022, then skyrocketed by 71.21% to $3.4 million in 2023, then skyrocketed by 81.05% to $6.1 million in 2024, then fell by 20.31% to $4.9 million in 2025.
- Its last three reported values are $4.9 million in Q4 2025, $5.0 million for Q3 2025, and $5.6 million during Q2 2025.